Fengchun Zhang

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 15

Top Topics

Systemic Lupus Erythematosus

Disease Activity

Top Venues

Annals of the rheumatic diseases

Clinical rheumatology

Journal of immunology research

This page only lists publications with an associated author ORCID identifier.

Publications

Sainan Bian, Li Wang, Yunyun Fei, Hua Chen, Fengchun Zhang
Glomerulonephritis in primary biliary cholangitis in China: an important complication. Clinical rheumatology 43 (8) (2024)
Sainan Bian, Li Wang, Yunyun Fei, Hua Chen, Fengchun Zhang
Glomerulonephritis in primary biliary cholangitis in China: an important complication. Clinical rheumatology (2024)
Sainan Bian, Li Wang, Yunyun Fei, Hua Chen, Fengchun Zhang
Glomerulonephritis in primary biliary cholangitis in China: an important complication. Clinical rheumatology 43 (8) (2024)
Di Wu, Jing Li, Dong Xu, Joan T Merrill, Ronald F Van Vollenhoven, Yi Liu, Jiankang Hu, Yang Li, Fen Li, Chenghui Huang, Guochun Wang, Xiao-Mei Li, Jianhong Zhao, Dongbao Zhao, Cibo Huang, Huaxiang Liu, Wei Wei, Guixiu Shi, Fuai Lu, Xiaoxia Zuo, Liqi Bi, Zhijun Li, Xiaoxia Wang, Miaojia Zhang, Ning Tie, Juan Li, Hanyou Mo, Jianmin Fang, Chunde Bao, Fengchun Zhang
Telitacicept in patients with active systemic lupus erythematosus: results of a phase 2b, randomised, double-blind, placebo-controlled trial. Annals of the rheumatic diseases 83 (4) (2024)
Di Wu, Jing Li, Dong Xu, Joan T Merrill, Ronald F Van Vollenhoven, Yi Liu, Jiankang Hu, Yang Li, Fen Li, Chenghui Huang, Guochun Wang, Xiao-Mei Li, Jianhong Zhao, Dongbao Zhao, Cibo Huang, Huaxiang Liu, Wei Wei, Guixiu Shi, Fuai Lu, Xiaoxia Zuo, Liqi Bi, Zhijun Li, Xiaoxia Wang, Miaojia Zhang, Ning Tie, Juan Li, Hanyou Mo, Jianmin Fang, Chunde Bao, Fengchun Zhang
Telitacicept in patients with active systemic lupus erythematosus: results of a phase 2b, randomised, double-blind, placebo-controlled trial. Annals of the rheumatic diseases 83 (4) (2024)
Di Wu, Jing Li, Dong Xu, Joan T Merrill, Ronald F Van Vollenhoven, Yi Liu, Jiankang Hu, Yang Li, Fen Li, Chenghui Huang, Guochun Wang, Xiao-Mei Li, Jianhong Zhao, Dongbao Zhao, Cibo Huang, Huaxiang Liu, Wei Wei, Guixiu Shi, Fuai Lu, Xiaoxia Zuo, Liqi Bi, Zhijun Li, Xiaoxia Wang, Miaojia Zhang, Ning Tie, Juan Li, Hanyou Mo, Jianmin Fang, Chunde Bao, Fengchun Zhang
Telitacicept in patients with active systemic lupus erythematosus: results of a phase 2b, randomised, double-blind, placebo-controlled trial. Annals of the rheumatic diseases 83 (4) (2024)
Di Wu, Jing Li, Dong Xu, Joan T Merrill, Ronald F Van Vollenhoven, Yi Liu, Jiankang Hu, Yang Li, Fen Li, Chenghui Huang, Guochun Wang, Xiao-Mei Li, Jianhong Zhao, Dongbao Zhao, Cibo Huang, Huaxiang Liu, Wei Wei, Guixiu Shi, Fuai Lu, Xiaoxia Zuo, Liqi Bi, Zhijun Li, Xiaoxia Wang, Miaojia Zhang, Ning Tie, Juan Li, Hanyou Mo, Jianmin Fang, Chunde Bao, Fengchun Zhang
Telitacicept in patients with active systemic lupus erythematosus: results of a phase 2b, randomised, double-blind, placebo-controlled trial. Annals of the rheumatic diseases 83 (4) (2024)
Sainan Bian, Li Wang, Yunyun Fei, Hua Chen, Fengchun Zhang
Glomerulonephritis in primary biliary cholangitis in China: an important complication. Clinical rheumatology 43 (8) (2024)
Di Wu, Jing Li, Dong Xu, Joan T Merrill, Ronald F Van Vollenhoven, Yi Liu, Jiankang Hu, Yang Li, Fen Li, Chenghui Huang, Guochun Wang, Xiao-Mei Li, Jianhong Zhao, Dongbao Zhao, Cibo Huang, Huaxiang Liu, Wei Wei, Guixiu Shi, Fuai Lu, Xiaoxia Zuo, Liqi Bi, Zhijun Li, Xiaoxia Wang, Miaojia Zhang, Ning Tie, Juan Li, Hanyou Mo, Jianmin Fang, Chunde Bao, Fengchun Zhang
Telitacicept in patients with active systemic lupus erythematosus: results of a phase 2b, randomised, double-blind, placebo-controlled trial. Annals of the rheumatic diseases 83 (4) (2024)
Di Wu, Jing Li, Dong Xu, Joan T Merrill, Ronald F Van Vollenhoven, Yi Liu, Jiankang Hu, Yang Li, Fen Li, Chenghui Huang, Guochun Wang, Xiao-Mei Li, Jianhong Zhao, Dongbao Zhao, Cibo Huang, Huaxiang Liu, Wei Wei, Guixiu Shi, Fuai Lu, Xiaoxia Zuo, Liqi Bi, Zhijun Li, Xiaoxia Wang, Miaojia Zhang, Ning Tie, Juan Li, Hanyou Mo, Jianmin Fang, Chunde Bao, Fengchun Zhang
Telitacicept in patients with active systemic lupus erythematosus: results of a phase 2b, randomised, double-blind, placebo-controlled trial. Annals of the rheumatic diseases (2023)
Suying Liu, Yanlei Yang, Liuting Zeng, Li Wang, Chengmei He, Zhilei Chen, Jinlei Sun, Taibiao Lyu, Mu Wang, Hua Chen, Fengchun Zhang
TOX promotes follicular helper T cell differentiation in patients with primary Sjögren's syndrome. Rheumatology (Oxford, England) (2022)
Fengchun Zhang, Jie Zheng, Yang Li, Guochun Wang, Mingjun Wang, Yin Su, Jieruo Gu, Xingfu Li, Damon L Bass, Myron Chu, Paula Curtis, Kathleen DeRose, Regina Kurrasch, Jenny Lowe, Paige Meizlik, David A Roth
Phase 3, long-term, open-label extension period of safety and efficacy of belimumab in patients with systemic lupus erythematosus in China, for up to 6 years. RMD open 8 (1) (2022)
Jie Zheng, Jieruo Gu, Yin Su, Yang Li, Xingfu Li, Cui Xiong, Hua Cao, Holly Quasny, Myron Chu, Paula Curtis, Kathleen DeRose, Regina Kurrasch, Paige Meizlik, David A Roth, Fengchun Zhang
Efficacy of belimumab in patients with systemic lupus erythematosus from North East Asia: Results of exploratory subgroup analyses. Modern rheumatology (2022)
Hermine I Brunner, Carlos Abud Mendoza, Masaaki Mori, Clarissa A Pilkington, Reema Syed, Syuji Takei, Diego O Viola, Richard A Furie, Sandra V Navarra, Fengchun Zhang, Damon L Bass, Gina Eriksson, Anne E Hammer, Beulah N Ji, Mohamed Okily, David A Roth, Holly A Quasny, Nicolino Ruperto
Efficacy and safety of belimumab in paediatric and adult patients with systemic lupus erythematosus: an across-study comparison. RMD open 7 (3) (2021)
Ying Pan, Jing Wang, Lan He, Fengchun Zhang
MicroRNA-34a Promotes EMT and Liver Fibrosis in Primary Biliary Cholangitis by Regulating TGF-β1/smad Pathway. Journal of immunology research 2021 (2021)